Navigation Links
VIVUS to Present at Two Upcoming Investor Conferences
Date:12/3/2010

MOUNTAIN VIEW, Calif., Dec. 3, 2010 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that senior management will present an overview of the company at two investment conferences during the month of December.The conference presentation schedule is as follows:Canaccord Genuity Cardiovascular, Diabetes & Obesity ConferenceDecember 8, 2010 at 12:30 p.m. PTNikko Hotel, San Francisco, CAPresenter: Charles Bowden, MD, director of clinical development2010 Deutsche Bank BioFEST ConferenceDecember 14, 2010 at 4:05 p.m. ETFour Seasons Hotel, Boston, MAPresenter: Timothy Morris, chief financial officerA live audio webcast and 30-day archive of the presentations will be available at http://ir.vivus.com.

About VIVUS VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead product in clinical development is QNEXA®, which also is in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS is in phase 3 development with avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction. For more information about the company, please visit www.vivus.com.

CONTACT:   VIVUS, Inc.Investor Relations:The Trout GroupTimothy E. MorrisBrian KorbChief Financial Officerbkorb@troutgroup.com650-934-5200646-378-2923
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Results From Phase 3 EQUATE Trial of VIVUS Qnexa Highlighted at European Congress on Obesity
2. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
3. Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting
4. VIVUS Announces Promotion of Peter Tam to President
5. VIVUS to Present at Lazard Capital Markets Healthcare Conference
6. VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity
7. VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results
8. VIVUS Announces Sale of MUSE Assets to Meda
9. FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®
10. VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results
11. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... N.C. , April 28, 2015 Chiltern, a ... Year (CRoY) winners in the UK, joining the five finalists ... the Gold Pharma in the CTA category and Helen ... Source professionals are working with Novartis. "We are ... as top performers in the industry," commented Nannette Penny ...
(Date:4/28/2015)... Minn. , April 28, 2015 ANI ... the Company plans to release its first quarter 2015 ... opening of the U.S. financial markets. The earnings press ... of the Company,s website, www.anipharmaceuticals.com . ... Executive Officer, and Charlotte C. Arnold , Vice ...
(Date:4/28/2015)... , April 28, 2015  Rosa & Co. ... drug-disease modeling and simulation, today announced its pleasure to ... exciting field of Quantitative Systems Pharmacology (QSP). The conference ... drug development.  ... Rosa,s lead sponsorship ...
Breaking Medicine Technology:Chiltern expands PharmaTimes Clinical Researcher of the Year involvement as sponsor, host and winner 2Chiltern expands PharmaTimes Clinical Researcher of the Year involvement as sponsor, host and winner 3ANI Pharmaceuticals Schedules Conference Call for First Quarter 2015 Financial Results 2Rosa & Co. is the Lead Partner for the Quantitative Systems Pharmacology (QSP) Congress in Basel, Switzerland and Will Present the Keynote Address 2Rosa & Co. is the Lead Partner for the Quantitative Systems Pharmacology (QSP) Congress in Basel, Switzerland and Will Present the Keynote Address 3
... a,licensee of Vical Incorporated (Nasdaq: VICL ), ... 3 clinical trial of its NV1FGF,angiogenesis therapy, which ... successful completion of the trial, called TAMARIS,sanofi-aventis expects ... The plasmid DNA (pDNA) therapy encodes Fibroblast Growth ...
... division of Wyeth (NYSE: WYE ), presented ... a selective estrogen receptor,modulator, at the American Society ... three-year study, data showed that bazedoxifene 20 mg ... new vertebral fractures by 42,percent and 37 percent, ...
Cached Medicine Technology:Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations 2Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations 3Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis 2Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis 3Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis 4
(Date:4/28/2015)... Md. (PRWEB) April 28, 2015 ... that advances the cause of medical foods and ... Kaycee Childress as the organization’s new executive director. ... face severe health consequences because of conditions and ... natural, life-sustaining diet. To live and thrive, ...
(Date:4/28/2015)... 2015 Board certified dermatologist Dr. ... a new, online acne treatment system that provides ... their specialized acne mapping technology. This online acne ... of California with internet access to receive full-service ... a physical office. The online acne treatment service ...
(Date:4/28/2015)... 2015 2015 Market Research Report ... professional and in-depth research report. The report provides ... overview, industry chain structure, international market analysis, and ... global (US, Europe, Japan, Asia) and Chinese market ... & economic situation analysis. The Global and Chinese ...
(Date:4/28/2015)... Two leaders in patient safety from the ... Hospital Review’s list of 50 Experts Leading the Field ... , director of the Armstrong Institute for Patient ... patient safety and quality at Johns Hopkins Medicine, and ... medical affairs and chief patient safety officer at All ...
(Date:4/28/2015)... Vancouver, BC (PRWEB) April 28, 2015 ... published a blog stating that it is smarter to ... of a personal injury claim. The blog reasons that ... lawyer since these professional are well-versed with the law ... the client would be able to on their own. ...
Breaking Medicine News(10 mins):Health News:Children's Medical Nutrition Alliance (CMNuA) Hires Kaycee Childress as Executive Director 2Health News:New Online Acne Treatment Service for California 2Health News:Centrifuges Market 2015 Global Research Report 2Health News:Centrifuges Market 2015 Global Research Report 3Health News:Johns Hopkins Medicine and All Children’s Hospital Leaders Recognized as Top Experts in Patient Safety 2Health News:Johns Hopkins Medicine and All Children’s Hospital Leaders Recognized as Top Experts in Patient Safety 3Health News:Johns Hopkins Medicine and All Children’s Hospital Leaders Recognized as Top Experts in Patient Safety 4Health News:Vancouver Personal Injury Lawyers Recently Stated in Latest Blog That It Is Smarter To Call A Lawyer Before ICBC 2
... SAN DIEGO, June 16 US Farms, Inc. (Pink Sheets: ... Hispanic focused web site www.jugodealoevera.com , which ... Aloe Vera Juice retails for $14.95 per bottle or wholesales for ... be ordered online with Visa, Master Card, Discover, or American Express ...
... Growing Non-Urban Market Segments , , DENVER, ... Med" or the "Company") (OTC Bulletin Board: GLOB), ... that its Wyndgate Technologies(R) division has licensed its ... hospital healthcare system. The organization will also ...
... , ALEXANDRIA, Va., June 16 Ambulatory surgery centers (ASCs) play a ... concludes a study issued today by the independent health economics and policy ... the growth in the number of ASCs between 2000 and 2007, include: ... ASCs are essential Medicare providers of surgical and cancer ...
... PORT ORANGE, Fla., June 16 Suddenly it happens, with ... find ourselves needing to parent our parents. , , ... to Dance Again," ( published by iUniverse ), ... own experience becoming caretaker for her mother, "She Just Wanted ...
... ... Today, HealthCare California announces that it is the first home health agency ... national leaders to utilize technology to improve health care. This home ... real-time access to information at the point of care, reduces costs, improves ...
... its counterparts in Europe -- , ... for a larger government role in health care and the ... United States may worry some pharmaceutical companies, all should share ... physician prescription decisions in the United States. , , ...
Cached Medicine News:Health News:US Farms, Inc. Launches Aloe Vera Juice Web Site for Hispanic Market 2Health News:US Farms, Inc. Launches Aloe Vera Juice Web Site for Hispanic Market 3Health News:Global Med Technologies(R) Licenses Transfusion Software Solution to Nationwide Healthcare System 2Health News:Global Med Technologies(R) Licenses Transfusion Software Solution to Nationwide Healthcare System 3Health News:Ambulatory Surgery Centers 'Pivotal' in Moving Outpatient Surgical Services Into Less Expensive, Clinically Appropriate Settings 2Health News:Ambulatory Surgery Centers 'Pivotal' in Moving Outpatient Surgical Services Into Less Expensive, Clinically Appropriate Settings 3Health News:Ambulatory Surgery Centers 'Pivotal' in Moving Outpatient Surgical Services Into Less Expensive, Clinically Appropriate Settings 4Health News:Ambulatory Surgery Centers 'Pivotal' in Moving Outpatient Surgical Services Into Less Expensive, Clinically Appropriate Settings 5Health News:'She Just Wanted to Dance Again': Navigate the Exchange of Parent-Caregiving Relationships Through Example, Advice 2Health News:New Online Home Health Service Launched in California to Expand Direct Patient Care Time While Lowering Costs 2Health News:New Online Home Health Service Launched in California to Expand Direct Patient Care Time While Lowering Costs 3Health News:Health Care Reform May Force U.S. Pharmaceutical Companies to Overhaul Sales Strategies, Says New Report From ZS Associates and eyeforpharma 2Health News:Health Care Reform May Force U.S. Pharmaceutical Companies to Overhaul Sales Strategies, Says New Report From ZS Associates and eyeforpharma 3Health News:Health Care Reform May Force U.S. Pharmaceutical Companies to Overhaul Sales Strategies, Says New Report From ZS Associates and eyeforpharma 4Health News:Health Care Reform May Force U.S. Pharmaceutical Companies to Overhaul Sales Strategies, Says New Report From ZS Associates and eyeforpharma 5